The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
“The purpose of the Millikin Innovation District is to provide space in the township for high quality office, medical, research, technology, advanced manufacturing, light industrial and other similar ...